Leukemia & Lymphoma

Papers
(The H4-Index of Leukemia & Lymphoma is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study86
Impact of SF3B1 mutation in myelofibrosis48
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma41
CRLF2 and IKZF1 abnormalities in childhood hematological malignancies other than B-cell Acute Lymphoblastic Leukemia34
Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant33
Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis27
Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma25
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination24
Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia23
Risk factors for mortality and re-admission of children with hematological malignancies to the intensive care unit due to sepsis22
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma22
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia21
Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management20
CD274 structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma20
MRD dynamics during maintenance therapy in 259 patients with nontransplant eligible multiple myeloma19
CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state19
Cigarette smoking is associated with worse prognosis in myelodysplastic syndromes and hematopoietic alterations in murine models19
Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclax19
Blinatumomab for the treatment of acute lymphoblastic leukemia in a real-world setting: clinical vignettes19
0.16619396209717